Claudia M. Lutzelschwab

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Evaluation of a novel experimental NanoQuil vaccine against Staphylococcus aureus-induced mastitis.

Evaluation of a novel experimental NanoQuil vaccine against Staphylococcus aureus-induced mastitis.

Journal: The Journal of dairy research

Published: May 22, 2026

Evaluation of the efficacy of polymeric antigen BLSOmp31 formulated in a new cage-like particle adjuvant (ISPA YOLK) administered by parenteral or mucosal routes against Brucella ovis in rams.

Evaluation of the efficacy of polymeric antigen BLSOmp31 formulated in a new cage-like particle adjuvant (ISPA YOLK) administered by parenteral or mucosal routes against Brucella ovis in rams.

Journal: Veterinary immunology and immunopathology

Published: July 10, 2025

A randomized, triple-blinded controlled clinical study with a novel disease-modifying drug combination in equine lameness-associated osteoarthritis.

A randomized, triple-blinded controlled clinical study with a novel disease-modifying drug combination in equine lameness-associated osteoarthritis.

Journal: Osteoarthritis and cartilage open

Published: June 02, 2023

Salivary biglycan-neo-epitope-BGN262: A novel surrogate biomarker for equine osteoarthritic sub-chondral bone sclerosis and to monitor the effect of short-term training and surface arena.

Salivary biglycan-neo-epitope-BGN262: A novel surrogate biomarker for equine osteoarthritic sub-chondral bone sclerosis and to monitor the effect of short-term training and surface arena.

Journal: Osteoarthritis and cartilage open

Published: October 25, 2022

Serum nerve growth factor in horses with osteoarthritis-associated lameness.

Serum nerve growth factor in horses with osteoarthritis-associated lameness.

Journal: Journal of veterinary internal medicine

Published: October 06, 2022

Evaluation of the efficacy of polymeric antigen BLSOmp31 formulated in a new cage-like particle adjuvant (ISPA) administered by parenteral or mucosal routes against Brucella ovis in BALB/c mice.

Evaluation of the efficacy of polymeric antigen BLSOmp31 formulated in a new cage-like particle adjuvant (ISPA) administered by parenteral or mucosal routes against Brucella ovis in BALB/c mice.

Journal: Research in veterinary science

Published: October 22, 2021

Development of a 3-transcript host expression assay to differentiate between viral and bacterial infections in pigs.

Development of a 3-transcript host expression assay to differentiate between viral and bacterial infections in pigs.

Journal: PloS one

Published: December 30, 2020

Polymeric antigen BLSOmp31 formulated with class B CpG-ODN in a nanostructure (BLSOmp31/CpG-ODN/Coa-ASC16) administered by parenteral or mucosal routes confers protection against Brucella ovis in Balb/c mice.

Polymeric antigen BLSOmp31 formulated with class B CpG-ODN in a nanostructure (BLSOmp31/CpG-ODN/Coa-ASC16) administered by parenteral or mucosal routes confers protection against Brucella ovis in Balb/c mice.

Journal: Research in veterinary science

Published: May 25, 2020

Early events following bovine leukaemia virus infection in calves with different alleles of the major histocompatibility complex DRB3 gene.

Early events following bovine leukaemia virus infection in calves with different alleles of the major histocompatibility complex DRB3 gene.

Journal: Veterinary research

Published: July 03, 2019

Co-infection with Mycobacterium bovis does not alter the response to bovine leukemia virus in BoLA DRB3*0902, genetically resistant cattle.

Co-infection with Mycobacterium bovis does not alter the response to bovine leukemia virus in BoLA DRB3*0902, genetically resistant cattle.

Journal: Research in veterinary science

Published: March 04, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026